Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Immunocore Holdings (IMCR) over the last 1 years, with Jun 2025 value amounting to -0.11%.

  • Immunocore Holdings' Return on Invested Capital rose 8.00% to -0.11% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.11%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.19% for FY2024, which is 3.00% down from last year.
  • Per Immunocore Holdings' latest filing, its Return on Invested Capital stood at -0.11% for Q2 2025, which was up 9.98% from -0.12% recorded in Q1 2025.
  • In the past 5 years, Immunocore Holdings' Return on Invested Capital ranged from a high of -0.11% in Q2 2025 and a low of -0.19% during Q2 2024.
  • For the 2-year period, Immunocore Holdings' Return on Invested Capital averaged around -0.16%, with its median value being -0.17% (2024).
  • Data for Immunocore Holdings' Return on Invested Capital shows a peak YoY increased of 8bps (in 2025) over the last 5 years.
  • Immunocore Holdings' Return on Invested Capital (Quarterly) stood at -0.18% in 2024, then increased by 8bps to -0.11% in 2025.
  • Its last three reported values are -0.11% in Q2 2025, -0.12% for Q1 2025, and -0.18% during Q4 2024.